Most recently, Yu et al. [35] demonstrated that GSS prevented NLRP3-mediated pyroptosis following ischemia by reducing the expression of cleaved-caspase-1, GSDMD-N, IL-1β, and IL-18, thereby limiting inflammatory cell death and restoring neurological function. The gene discussed is NLRP3; the disease is ischemia.